Synthesis and structure–activity relationships of novel, substituted 5,6-dihydrodibenzo[a,g]quinolizinium P2X7 antagonists
摘要:
Iminium quaternary protoberberine alkaloids (QPA) have been found to be novel P2X(7) antagonists. To assess their structure-activity relationships, these compounds were modified at their R-1 and R-2 groups and assayed for their ability to inhibit the 2'(3')-O-(4-benzoylbenzoyl)-ATP (BzATP)-induced uptake of fluorescent ethidium by HEK-293 cells stably expressing the human P2X(7) receptor, and their ability to inhibit BzATP-induced IL-1 beta release by differentiated THP-1 cells. Compounds 15a and 15d, with alkyl groups at the R-1 position, and especially compound 19h, with the 2-NO2-4,5-dimethoxy-benzyl group at the R-2 position, had potent inhibitory efficacy as P2X(7) antagonists. (C) 2008 Elsevier Ltd. All rights reserved.
[EN] PROCESS FOR THE PREPARATION OF N-IODOAMIDES<br/>[FR] PROCÉDÉ DE PRÉPARATION DE N-IODOAMIDES
申请人:TECHNION RES & DEV FOUNDATION
公开号:WO2015068159A3
公开(公告)日:2015-07-16
Aliphatic C–H Bond Iodination by a <i>N</i>-Iodoamide and Isolation of an Elusive <i>N</i>-Amidyl Radical
作者:Alexander Artaryan、Artur Mardyukov、Kseniya Kulbitski、Idan Avigdori、Gennady A. Nisnevich、Peter R. Schreiner、Mark Gandelman
DOI:10.1021/acs.joc.7b00557
日期:2017.7.21
Contrary to C–H chlorination and bromination, the direct iodination of alkanes represents a great challenge. We reveal a new N-iodoamide that is capable of a direct and efficient C–H bond iodination of various cyclic and acyclic alkanes providing iodoalkanes in good yields. This is the first use of N-iodoamide for C–H bond iodination. The method also works well for benzylic C–H bonds, thereby constituting
Synthesis and structure–activity relationships of novel, substituted 5,6-dihydrodibenzo[a,g]quinolizinium P2X7 antagonists
作者:Ga Eun Lee、Ho-Sung Lee、So Deok Lee、Jung-Ho Kim、Won-Ki Kim、Yong-Chul Kim
DOI:10.1016/j.bmcl.2008.11.088
日期:2009.2
Iminium quaternary protoberberine alkaloids (QPA) have been found to be novel P2X(7) antagonists. To assess their structure-activity relationships, these compounds were modified at their R-1 and R-2 groups and assayed for their ability to inhibit the 2'(3')-O-(4-benzoylbenzoyl)-ATP (BzATP)-induced uptake of fluorescent ethidium by HEK-293 cells stably expressing the human P2X(7) receptor, and their ability to inhibit BzATP-induced IL-1 beta release by differentiated THP-1 cells. Compounds 15a and 15d, with alkyl groups at the R-1 position, and especially compound 19h, with the 2-NO2-4,5-dimethoxy-benzyl group at the R-2 position, had potent inhibitory efficacy as P2X(7) antagonists. (C) 2008 Elsevier Ltd. All rights reserved.